D. Canioni et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DEFICIENCY NEEDS AN EARLY DIAGNOSIS - REPORT OF A CASE, PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 17(4), 1997, pp. 645-651
Major histocompatibility complex (MHC) class II deficiency is a rare p
rimary immunodeficiency disorder characterized by defects in human leu
kocyte antigen class II expression, inconsistent expression of human l
eukocyte class I molecules, and a lack of cellular and humoral immune
responses to foreign antigens. Clinical onset occurs early in life wit
h recurrent infections and chronic diarrhea. The prognosis is poor, an
d mean age at the time of death is 4 years. The only curative treatmen
t is bone marrow transplantation (BMT), which allows the immune system
's reconstitution. BMT should be done early in life, because long-term
survival seems to depend on the number of previous viral infections.
We report the case of an MHC class II deficiency discovered late in a
4-year-old girl by means of immunohistochemistry of small bowel biopsy
revealing the absence of MHC class II expression. The child received
a BMT twice but died because of a overwhelming viral infection. This c
ase underlines the necessity to explore children presenting with infec
tions and chronic diarrhea in order to find MHC class II deficiency. U
sually, diagnosis is performed on cytospins, but when it has been miss
ed clinically, it can be performed by using immunohistochemistry on sm
all bowel biopsies.